Novartis AG - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US66987V1098
121,00 € 0,00 (0,00%)
2026-06-04
DEL PRIS
SecurityDE:NOTA / Novartis AG - Depositary Receipt (Common Stock)
InstitutionBowen Hanes & Co Inc
Latest Disclosed Ownership1,400 shares
Latest Disclosed Value $ 213,850
Bowen Hanes & Co Inc reports 50.00% decrease in ownership of NOTA / Novartis AG - Depositary Receipt (Common Stock)

On May 14, 2026 - Bowen Hanes & Co Inc filed a 13F-HR form disclosing ownership of 1,400 shares of Novartis AG - Depositary Receipt (Common Stock) (DE:NOTA) valued at $179,900 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 2,800 shares of Novartis AG - Depositary Receipt (Common Stock). The current value of the position is $169,400 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F NOVARTIS AG ADS COM 66987V109 1,400 -1,400 -50.00 214 0.0052
2026-02-10 2025-12-31 13F NOVARTIS AG ADS COM 66987V109 2,800 2,800 0 0.0097
2022-05-12 2022-03-31 13F NOVARTIS AG ADS COM 66987V109 0 -4,745 -100.00 0 -100.00
2022-02-11 2021-12-31 13F NOVARTIS AG ADS COM 66987V109 4,745 0 0.00 415 6.96 0.0117
2021-11-15 2021-09-30 13F NOVARTIS AG ADS COM 66987V109 4,745 0 0.00 388 -10.39 0.0119
2021-08-12 2021-06-30 13F NOVARTIS AG ADS COM 66987V109 4,745 0 0.00 433 6.65 0.0132
2021-05-18 2021-03-31 13F/A-1 NOVARTIS AG ADS COM 66987V109 4,745 0 0.00 406 -9.37 0.0130
2021-05-13 2021-03-31 13F NOVARTIS AG ADS COM 66987V109 4,745 0 406 0.0137
2021-02-08 2020-12-31 13F NOVARTIS AG ADS COM 66987V109 4,745 -3,435 -41.99 448 -36.99 0.0149
2021-02-08 2020-09-30 13F/A-1 NOVARTIS AG ADS COM 66987V109 8,180 -1,125 -12.09 711 -12.55 0.0256
2020-11-02 2020-09-30 13F NOVARTIS AG ADS COM 66987V109 8,305 -1,000 722 27,221.8619
2021-02-08 2020-06-30 13F/A-1 NOVARTIS AG ADS COM 66987V109 9,305 -791 -7.83 813 -2.28 0.0328
2020-08-14 2020-06-30 13F NOVARTIS AG ADS COM 66987V109 9,305 -791 813 34,218.1654
2021-02-08 2020-03-31 13F/A-1 NOVARTIS AG ADS COM 66987V109 10,096 1,000 10.99 832 -3.37 0.0407
2020-05-14 2020-03-31 13F NOVARTIS AG ADS COM 66987V109 10,096 1,000 832 41,794.4907
2020-02-13 2019-12-31 13F NOVARTIS AG ADS COM 66987V109 9,096 0 0.00 861 8.99 0.0354
2019-11-13 2019-09-30 13F NOVARTIS AG ADS COM 66987V109 9,096 -400 -4.21 790 -8.88 0.0336
2019-08-13 2019-06-30 13F NOVARTIS AG ADS COM 66987V109 9,496 3,440 56.80 867 48.97 0.0373
2019-05-13 2019-03-31 13F NOVARTIS AG ADS COM 66987V109 6,056 126 2.12 582 14.34 0.0258
2019-02-13 2018-12-31 13F NOVARTIS AG ADS COM 66987V109 5,930 -4,520 -43.25 509 -43.44 0.0256
2018-11-07 2018-09-30 13F NOVARTIS AG ADS COM 66987V109 10,450 10,450 76.22 900 76.82 0.0396
2016-05-16 2016-03-31 13F NOVARTIS AG ADS COM 66987V109 0 -51,345 -100.00 0 -100.00
2016-02-17 2015-12-31 13F NOVARTIS AG ADS COM 66987V109 51,345 -236,500 -82.16 4,418 -83.30 0.2473
2015-11-12 2015-09-30 13F NOVARTIS AG ADS COM 66987V109 287,845 -51,125 -15.08 26,459 -20.62 1.5223
2015-08-14 2015-06-30 13F NOVARTIS AG ADS COM 66987V109 338,970 35 0.01 33,334 -0.26 1.6566
2015-05-13 2015-03-31 13F NOVARTIS AG ADS COM 66987V109 338,935 4,280 1.28 33,422 7.78 1.6069
2015-02-13 2014-12-31 13F NOVARTIS AG ADS COM 66987V109 334,655 -6,615 -1.94 31,009 -3.47 1.5201
2014-11-12 2014-09-30 13F NOVARTIS AG ADS COM 66987V109 341,270 -50,745 -12.94 32,124 -9.48 1.5698
2014-08-13 2014-06-30 13F NOVARTIS AG ADS COM 66987V109 392,015 10,005 2.62 35,489 9.27 1.6529
2014-05-15 2014-03-31 13F NOVARTIS AG ADS COM 66987V109 382,010 5,205 1.38 32,478 7.23 1.5712
2014-02-18 2013-12-31 13F NOVARTIS AG ADS COM 66987V109 376,805 -7,550 -1.96 30,288 2.73 1.4730
2013-11-15 2013-09-30 13F NOVARTIS AG ADS COM 66987V109 384,355 -12,120 -3.06 29,484 5.17 1.5073
2013-08-14 2013-06-30 13F NOVARTIS AG ADS COM 66987V109 396,475 396,475 28,035 1.5015
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.